Kappa - B.1.617.1
WHO Designation
Formerly Monitored Variant
Alternative names
G/452R.V3, Indian Variant, Kappa
First publication
Cherian et al, BioRxiv (May 2021)
Reference sequences given in literature
GISAID sequences based on mutations given at SARS-CoV-2 Variant Classifications and Definitions of CDC - U.S. Department of Health & Human Services
Sequence used for library generation
EPI_ISL_1372093 (Gisaid accession ID)
JPT’s products
PepMix™ SARS-CoV-2 (Spike B.1.617.1 / Kappa) : Entire spike protein
PepMix™ SARS-CoV-2 (S-RBD B.1.617.1 / Kappa) : Spike receptor binding domain
Multiwell PepStar™ SARS-COV-2 (Spike) Wild type + Omicron : Entire spike protein
Mutations in spike glycoprotein
T0095I, G0142D, E0154K, L0452R, E0484Q, D0614G, P0681R, Q1071H